Tozaro Limited
MIP Discovery specializes in developing synthetic affinity reagents for various applications, particularly in cell and gene therapy. They offer a unique approach to detection, capture, and purification of challenging target molecules, providing a cost-effective and reliable alternative to traditional methods.
Founded: 11 Mar 2015
Industries:
72190 - Other research and experimental development on natural sciences and engineering
Website: mipdiscovery.com
Phone: +44(0)1234589725
Email: enquiries@mipdiscovery.com
Location: Sharnbrook
Products & Services
• aav
• affinity purification
• affinity reagents
• biotechnology company
• cell and gene therapy
• covid-19 mip
• endotoxins
• lentiviral and aav affinity reagents
• lentivirus
• mip technology
• molecularly imprinted polymers
• pei
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
5
Shareholders
47
Controllers (PSC)
1
Mercia Fund Management (nominees) Limited
Corporate Director • United Kingdom
Michele Pedrocchi
Director • Swiss • Lives in Switzerland • Born in Dec 1964
Guy Cameron Leaver
Director • British • Lives in England • Born in Apr 1964
Elizabeth Edmonds
Director • British • Lives in England • Born in Sept 1971
Jason Hardwick Slingsby
Director • British • Lives in England • Born in May 1971
Basic Information
LTD
11 Mar 2015
ENGLAND WALES
Yes
Industry Classification
72190
Company Attributes
N/A
N/A
N/A
N/A
Summary
20
Officers
1
PSCs
0
Filings